enteric-coated tablets
Magnesium lactate + Pyridoxine hydrochloride
This medicine should always be used exactly as described in the patient leaflet or as directed by a doctor or pharmacist.
Magvit B is a medicine containing magnesium salt of lactic acid and vitamin B (pyridoxine hydrochloride).
Magnesium regulates the flow of ions in the cell - reduces nervous and muscular excitability.
It interacts with calcium ions in the formation of bone structure.
Symptoms of magnesium deficiency include hyperexcitability, difficulty concentrating and falling asleep,
increased susceptibility to stress and muscle function disorders. Magnesium deficiency increases the risk of
hypertension, coronary heart disease, heart attack, and arrhythmias.
Vitamin B facilitates the absorption and transport of magnesium from the gastrointestinal tract into the blood, and then
through biological membranes into the cells, and reduces the amount of magnesium excreted in the urine,
allowing for the maintenance of a normal intracellular magnesium pool. Additionally, the amount of vitamin B contained in one tablet of Magvit B is sufficient to protect the body against deficiency. Vitamin B deficiency in humans can manifest as skin and mucous membrane inflammation, mental disorders, convulsions, polyneuritis, and anemia resulting from hemoglobin deficiency.
The indication for the use of Magvit B is the prevention and treatment of magnesium and/or vitamin B deficiencies.
Prophylactically, Magvit B is used:
Magvit B is used as a supplement to the treatment of:
Before starting to take Magvit B, you should discuss it with your doctor or pharmacist.
When taking oral tetracycline preparations, a three-hour interval should be maintained between the administration of the antibiotic and Magvit B due to the reduced absorption of tetracyclines from the gastrointestinal tract. Patients with heart and kidney function disorders should consult their doctor before taking the medicine.
You should tell your doctor or pharmacist about all the medicines you are taking or have recently taken, as well as any medicines you plan to take.
Magnesium reduces the absorption of theophylline, tetracyclines, iron preparations, fluorine compounds, and oral anticoagulant medications from the warfarin group.
Phosphates, high doses of calcium, excessive lipids (fats), phytates (found in coarse-grained cereal products) reduce magnesium absorption from the gastrointestinal tract. Diuretic medications, cisplatin, cycloserine, mineralocorticosteroids, and increased magnesium excretion in the urine. Aminoglycosides, muscle relaxants, and colistin used simultaneously with magnesium preparations can cause muscle paralysis. As a result of urine alkalization, there is a decrease in renal excretion of quinidine, which is associated with the risk of its overdose. Vitamin B may reduce the concentration of phenytoin in blood serum. The use of cycloserine, hydralazine, isoniazid, penicillamine, and oral contraceptives leads to an increased demand for vitamin B.
The medicine should not be taken on an empty stomach, as it may cause diarrhea.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Magvit B can be used during pregnancy and lactation only in agreement with the doctor.
No negative effect on the ability to drive and use machines has been observed.
This medicine should always be taken exactly as described in the patient leaflet or as directed by a doctor or pharmacist. In case of doubt, you should consult a doctor or pharmacist.
Prophylactically
1 time a day 2 tablets or 1 to 2 tablets 2 times a day
According to the doctor's recommendation.
Therapeutically
Only with a doctor's prescription.
The medicine should be taken with water.
In case of overdose, whose symptoms are: nausea and vomiting, diarrhea, blood pressure drop, muscle weakness, breathing difficulties, arrhythmias, sensory disturbances, limb pain, abundant oral hydration should be applied.
A double dose should not be taken to make up for a missed dose.
In case of any further doubts related to the use of this medicine, you should consult a doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Rarely, gastrointestinal disorders may occur. When following the recommended doses, side effects do not occur.
In some people, during the use of Magvit B, other side effects may occur.
If any side effects occur, including any side effects not listed in the leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to: the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel. +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 25°C. Protect from light.
Store in the original packaging.
Do not use Magvit B after the expiry date stated on the packaging. The expiry date refers to the last day of the given month.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substances of the medicine are: magnesium ions (in the form of magnesium lactate dihydrate) and pyridoxine hydrochloride (vitamin B).
One tablet contains 48 mg of magnesium lactate dihydrate and 5 mg of pyridoxine hydrochloride.
The other ingredients are:
Magvit B is a white, oval tablet.
The immediate packaging is an aluminum/PVC blister pack in a cardboard box.
The packaging contains 20, 30, or 50 tablets.
Angelini Pharma Polska Sp. z o.o.
Aleje Jerozolimskie 181B, 02-222 Warsaw
tel.: (22) 70 28 200
e-mail: angelini@angelini.pl
Wörwag Pharma Operations Sp. z o.o.
ul. Gen. Mariana Langiewicza 58
95-050 Konstantynów Łódzki
The patient leaflet in a format suitable for the blind and visually impaired is available at the marketing authorization holder's headquarters.
Date of the last update of the leaflet:April 2022
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.